Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain StimulationNot Yet Recruiting
NCT07725315NAUpdated Jul 24, 2026
Sponsor: University of Alabama at Birmingham
Deep Brain Stimulation · PARKINSON DISEASE (Disorder)
United States
Effect of Hand Rehabilitation on Cognitive Function in Patients With PDNot Yet Recruiting
NCT07702929NAUpdated Jul 24, 2026
Sponsor: Isfahan University of Medical Sciences
PARKINSON DISEASE (Disorder)
Effects of Whole Body Vibration Versus Proprioceptive Neuromuscular Facilitation Pattern With Rhythmic Based Training on Clinical Outcomes in Patients With Parkinson's Disease.Completed
NCT07723027NAUpdated Jul 23, 2026
Sponsor: Lahore University of Biological and Applied Sciences
Parkinson Disease
Pakistan
"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"Recruiting
NCT07710625N/AUpdated Jul 22, 2026
Sponsor: Acibadem University
Parkinson Disease · Temperature Sensivity
Turkey (Türkiye)
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease DementiaCompleted
NCT03413384Phase 2Updated Jul 22, 2026
Sponsor: BrainX Corporation
Parkinson's Disease Dementia
Taiwan
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)Completed
NCT03924856Phase 3Updated Jul 22, 2026
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Australia, Belgium, Canada, Denmark +17 more
TMS in Anxiety-Parkinson's DiseaseEnrolling By Invitation
NCT06999330NAUpdated Jul 22, 2026
Sponsor: HealthPartners Institute
Parkinsons Disease (PD) · Anxiety
United States
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active Not Recruiting
NCT04895358Phase 3Updated Jul 22, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +26 more
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's DiseaseRecruiting
NCT05266417Phase 2Updated Jul 22, 2026
Sponsor: Gateway Institute for Brain Research
Parkinson Disease
United States
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseaseNot Yet Recruiting
NCT07187466Phase 4Updated Jul 22, 2026
Sponsor: VA Office of Research and Development
Overactive Bladder · Parkinson Disease
United States
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)Completed
NCT04210115Phase 3Updated Jul 22, 2026
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma (ESCC) · Gastroesophageal Junction Carcinoma (GEJC) · Esophageal Adenocarcinoma (EAC)
United States, Argentina, Belgium, Brazil, Canada +22 more
Novel DBS Stimulation Patterns for Treatment of Parkinson's DiseaseRecruiting
NCT04799470NAUpdated Jul 22, 2026
Sponsor: University of Nebraska
Parkinson's Disease
United States
Impact of Exercise on Muscle Metabolism and Function for Persons With ParkinsonsCompleted
NCT07720713NAUpdated Jul 22, 2026
Sponsor: University of Texas Southwestern Medical Center
Parkinson
United States
Motor Network PhysiologyRecruiting
NCT04957095NAUpdated Jul 22, 2026
Sponsor: University of Texas Southwestern Medical Center
Parkinson Disease · Essential Tremor
United States
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)Recruiting
NCT07720765N/AUpdated Jul 22, 2026
Sponsor: IRCCS San Raffaele
Multiple Sclerosis · Alzheimer Disease · Parkinson Disease · Migraine
Italy
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung CancerRecruiting
NCT05142189Phase 1Updated Jul 22, 2026
Sponsor: BioNTech SE
Non-Small Cell Lung Cancer
United States, Australia, Germany, Hungary, Poland +3 more
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's DiseaseNot Yet Recruiting
NCT07718659Phase 1Updated Jul 22, 2026
Sponsor: Qianfoshan Hospital
Parkinson's Disease (PD) · Parkinsonian Disorders
China
Subthalamic Nucleus (STN)-Targeted Transcranial Temporal Interference Stimulation (TIS) for Parkinson's Disease: Efficacy and Safety From a Single-Center, Prospective, Double-Blind Randomized Controlled TrialCompleted
NCT07361250NAUpdated Jul 21, 2026
Sponsor: Tang Zhouping
Parkinson Disease
China
Body Composition and Blood-Based Prognostic Markers in Immunotherapy-Treated Metastatic Non-Small Cell Lung CancerCompleted
NCT07192926N/AUpdated Jul 21, 2026
Sponsor: Ankara Etlik City Hospital
Metastatic Non-small Cell Lung Cancer · Neoplasm
Turkey (Türkiye)
The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson DiseaseRecruiting
NCT07026734NAUpdated Jul 21, 2026
Sponsor: University of Florida
Parkinson Disease, Idiopathic
United States
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's SyndromeRecruiting
NCT07568067NAUpdated Jul 21, 2026
Sponsor: Ke Dong, MD
Parkinson Disease · Parkinson Disease, Secondary
China
Neuro-immune Interactome in Parkinson's DiseaseActive Not Recruiting
NCT07026929N/AUpdated Jul 21, 2026
Sponsor: Yale University
Parkinson Disease
United States
A Study of Buntanetap in Participants With PDRecruiting
NCT07284784Phase 2, Phase 3Updated Jul 21, 2026
Sponsor: Annovis Bio Inc.
Parkinson's Disease (PD) · Deep Brain Stimulation
United States
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)Active Not Recruiting
NCT07213648NAUpdated Jul 20, 2026
Sponsor: University of Virginia
Huntington Disease · Parkinson Disease
United States
The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseRecruiting
NCT07610369Phase 2Updated Jul 20, 2026
Sponsor: Yale University
Depression · Parkinson's Disease (PD)
United States

Previous page Next page